|
TCMBANKIN000151 |
Gypenoside XX |
gypenoside xx |
C60H102O28 |
1271.44 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)CO)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C)O)C)C)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)O |
|
TCMBANKIN000594 |
Gypenoside LXXVI |
gypenoside lxxvi |
C36H62O9 |
638.87 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)CO)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C |
|
TCMBANKIN000844 |
Gypenoside LXIV |
gypenoside lxiv |
C47H80O18 |
933.13 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)CO)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)O)O)O)O)C |
|
TCMBANKIN000962 |
campesterol |
campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 |
C28H48O |
400.68 |
CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN001123 |
Gypenoside XXXVI |
gypenoside xxxvi |
|
1091.44 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C)(CCC=C(C)C)C3CCC4(C3CCC5C4(CCC6C5(CCC(C6(C)C)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)CO)O)O)O)C=O)C)C)O)O)O)O)O)O |
|
TCMBANKIN001149 |
Gypenoside XXXIX |
gypenoside xxxix |
C42H72O14 |
801.01 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)CO)C)O)C)O)C |
|
TCMBANKIN001278 |
N,N-Dimethylconiine |
n,n-dimethylconiine |
|
156.33 |
CCCC1CCCC[N+]1(C)C |
|
TCMBANKIN003052 |
Decylaldehyde DMA |
Capraldehyde dimethyl acetal; Decanal dimethyl acetal; AI3-36022; Aldehyde C-10 dimethylacetal; W236306_ALDRICH; EINECS 231-928-6; 7779-41-1; DECANAL, DIMETHYLACETAL; BRN 4242149; Decanal, dimethyl acetal; FEMA No. 2363; Decylaldehyde dimethylacetal; Decane, 1,1-dimethoxy-; Decanal, dimethyl acetal (8CI); 1,1-Dimethoxydecane; 10,10-Dimethoxydecane; NSC 46132; Decylaldehyde dimethyl acetal; NSC46132 |
C12H26O2 |
202.33 |
CCCCCCCCCC(OC)OC |
|
TCMBANKIN003434 |
Gypenoside LV_qt |
Gypenoside LXXIX_qt; Gypenoside LXIII_qt; Gypenoside XXXVIII_qt |
C42H72O14 |
801.01 |
|
|
TCMBANKIN003803 |
ginsenoside Rb3_qt |
gensenoside- Rb3_qt; ginsenoside- Rb3_qt; gensenoside Rb3_qt |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN004036 |
23-o-acetyl-3β,12β,23s,24r-tetrahydroxy-20s,25-epoxydammarane 3-o-[β-d-xylopyranosyl(1→2)]-β-d-glucopyranoside |
|
C43H72O15 |
|
CC(=O)OC1CC(OC(C1O)(C)C)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C |
|
TCMBANKIN004454 |
Gypenoside LXV_qt |
Gypenoside LXXII_qt; Gypenoside LIV_qt; Gypenoside LXII_qt; Gypenoside LXXVI_qt; Gypenoside LXIV_qt; Gypenoside LXXIV_qt |
C41H70O13 |
770.99 |
|
|
TCMBANKIN004606 |
p-Mercaptophenol |
637-89-8; NSC46192; BRN 2039306; Hydroquinone, monothio-; Monothiohydroquinone; Phenol, 4-mercapto-; p-Hydroxythiophenol; AI3-32249; 275395_ALDRICH; 63764_FLUKA; NSC 46192; Phenol, 4-mercapto- (9CI); 4-Hydroxybenzenethiol; EINECS 211-307-6; 4-sulfanylphenol; Phenol, p-mercapto-; Phenol, p-mercapto- (8CI); WLN: L6V DYJ DUS; Usaf B-57; 4-Hydroxythiophenol; Thiohydroquinone; 559938_ALDRICH; 4-Mercaptophenol |
C6H6OS |
126.18 |
C1=CC(=CC=C1O)S |
|
TCMBANKIN004693 |
Gypenoside XIX |
gypenoside xix |
C54H92O23 |
1109.29 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C)(CCC=C(C)CO)C3CCC4(C3C(CC5C4(CCC6C5(CCC(C6(C)C)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)C)O)C)O)O)O)O)O)O |
|
TCMBANKIN005218 |
Gypenoside XXII |
gypenoside xxii |
C53H90O23 |
1095.27 |
CC(=CCCC(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)CO)C)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
|
TCMBANKIN005294 |
ginsenoside rd_qt |
ginsenoside- F3_qt; ginsenoside F2_qt; notoginsenosider4_qt |
C42H72O13 |
785.01 |
|
|
TCMBANKIN005354 |
Gypenoside LXXI_qt |
|
C53H90O23 |
1095.27 |
|
|
TCMBANKIN006177 |
3β,12β,23s,24r-tetrahydroxy-20s,25-epoxy-dammarane 3-o-[β-d-xylopyranosyl(1→2)][β-d-xylopyranosyl-(1→6)]-β-d-glucopyra-noside |
|
C46H78O18 |
|
|
|
TCMBANKIN006666 |
3β,19,20s,21-tetrahydroxydammar-24-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyra-nosyl(1→3)]-β-d-glucopyranosyl}-21-o-β-d-glucopyranoside |
|
C53H90O22 |
|
|
|
TCMBANKIN006742 |
Gypenoside XXXIX_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN006987 |
Gulutamine |
25513-46-6; G1251_SIGMA; Glutamic acid, L-, peptides; Acidum glutamicum; BPBio1_001132; L-Glutamic acid (9CI); AIDS071819; nchembio.2007.55-comp22; (S)-2-aminopentanedioic acid; L-Glutaminic acid; 26717-13-5; E 620; Biomol-NT_000170; Lopac0_000529; D00007; L-Glutamic acid, homopolymer (9CI); Poly(alpha-L-glutamic acid); NCGC00024502-01; (2S)-2-aminoglutaric acid; NCGC00024502-03; 24938-00-9; PDSP1_001539; L-Glutamic acid (JAN); W328502_ALDRICH; alpha-L-Glutamic acid polymer; HSCI1_000269; 09581_FLUKA; AIDS-071819; G5667_SIGMA; L-Glutaminsaeure; 49449_FLUKA; nchembio816-comp2; PDSP2_000127; Glutamic acid polymer; PDSP2_001523; alpha-Glutamic acid; G8415_SIGMA; C00025; 84960-48-5; Tocris-0218; CHEBI:16015; L-alpha-Aminoglutaric acid; PDSP1_000128; Glutamic acid, L- (7CI,8CI); (2S)-2-aminopentanedioic acid; POLYGLUTAMIC ACID; LS-2330; Gulutamine (USP) |
C5H9NO4 |
147.13 g/mol |
C(CC(=O)O)C(C(=O)O)N |
|
TCMBANKIN007364 |
Gypnoside V_qt |
Ginsenoside-Ra2_qt; Gypenoside XI_qt; Ginsenoside-Rb3_qt; Gypenoside VII_qt; Gypenoside XII_qt; Ginsenoside-Ra0_qt; Dammarane Sapogenin; Gypenoside XVII_qt; Gypenoside IX_qt; Gypenoside LXXV_qt; Gypenoside LXIX_qt; Gypenoside XIX_qt; Gypenoside XV_qt; Gypenoside XIII_qt; Gypinoside III_qt; ginsenoside Rd2_qt; Notoginseoside Fe_qt; Gypenoside IV_qt; Ginsenoside-Rs2_qt; Ginsenoside-Rs1_qt; Gypenoside XVI_qt; Gypinoside VII_qt; Ginsenoside-Ra3_qt; Gypenoside II_qt; Ginsenoside-Ra1_qt; Gypenoside VI_qt |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN007426 |
Gypenoside XLVI |
gypenoside xlvi |
C48H82O19 |
963.15 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CC(C(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
|
TCMBANKIN007622 |
Gypenoside LXXII |
gypenoside lxxii |
C48H82O18 |
947.15 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)C)OC7C(C(C(C(O7)CO)O)O)O)C)O)C)CO)O)O)O)O)O)O |
|
TCMBANKIN007884 |
Gypenoside XXXV_qt |
Gypenoside XXXIII_qt; Gypenoside XXVI_qt; Gypenoside XXXIV_qt |
C42H70O14 |
799 |
|
|
TCMBANKIN008317 |
Gypenoside LIX |
gypenoside lix |
C41H70O14 |
786.99 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3CCC(C4(C)C)O)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)CO |
|
TCMBANKIN008481 |
Ruvoside |
3-[(5R,10R,14S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; ruvoside; AC1O3DXD |
C30H46O9 |
550.68 |
[HH].CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)CO)O)OC)O |
|
TCMBANKIN008783 |
(3β, 12α,13α)-3,12-dihydroxypimara |
|
C20H30O3 |
|
CC1(C2CC=C3CC(C(CC3C2(CC(=O)C1O)C)O)(C)C=C)C |
|
TCMBANKIN008882 |
phosphatidyl ethanolamine |
phosphatidylethanolamine |
|
716.11 |
CCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCC |
|
TCMBANKIN009441 |
4α,14α-dimethyl-5α-ergosta-7,9(11),24(28)-trien-3β-ol |
|
|
424.78 |
|
|
TCMBANKIN009698 |
23-o-acetyl-3β,12β,23s,24r-tetrahydroxy-20s,25-epoxydammarane 3-o-[β-d-xylopyranos-yl(1→2)]-β-d-xylopyranoside |
|
C42H70O14 |
|
CC(=O)OC1CC(OC(C1O)(C)C)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C |
|
TCMBANKIN009883 |
Gypenoside I_qt |
ginsenoside-F2_qt; ginsenoside-Ra0_qt; gypenoside XI_qt; ginsenoside- Rc_qt; ginsenoside- F2_qt; gypenosideXVII_qt; Gypenoside XVII_qt; ginsenoside- Rb2_qt |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN010419 |
Gypenoside XXIX_qt |
Gypenoside XXIV_qt |
C41H68O12 |
752.97 |
|
|
TCMBANKIN010698 |
Gypenoside XXVIII_qt |
|
|
416.71 |
|
|
TCMBANKIN010706 |
Gypenoside XXXVIII |
gypenoside xxxviii |
C42H72O14 |
801.01 |
CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)CO)C)C)O)C |
|
TCMBANKIN010974 |
cyclopentyl 2-methoxyacetate |
2-methoxyacetic acid cyclopentyl ester; Methoxyacetic acid, cyclopentyl ester; cyclopentyl 2-methoxyethanoate |
C8H14O3 |
158.19 g/mol |
COCC(=O)OC1CCCC1 |
|
TCMBANKIN011010 |
1-methyl-5-isopropenyl cyclohexene |
1-methyl-5-(1-methylethenyl)-cyclohexene |
C10H16 |
136.23 |
CC1=CCCC(C1)C(=C)C |
|
TCMBANKIN011142 |
(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal |
(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-hexanal; (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hexanal; (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hexanal; (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]hexanal |
C12H22O11 |
342.3 |
|
|
TCMBANKIN011319 |
germacrene |
germacrene d; Germacrene-D |
C15H24 |
204.35 |
CC1=CCCC(=CCC(CC1)C(=C)C)C |
|
TCMBANKIN011369 |
Gypenoside XLVIII_qt |
|
C53H88O22 |
1077.25 |
|
|
TCMBANKIN011514 |
Gypenoside LVII |
gypenoside lvii |
C47H80O18 |
933.13 |
C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.C.CCC1CC(C(C(C1C)C)C)COC.O.O.O.O.O.O.O.O.O.O |
|
TCMBANKIN011967 |
Gypenoside XXVII_qt |
|
C42H72O13 |
785.01 |
|
|
TCMBANKIN012765 |
Gypenoside I |
gypenoside i |
C60H102O27 |
1255.44 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C)O)C)C)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)O |
|
TCMBANKIN013923 |
Gypenoside LI_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN014056 |
19-oxo-3β,20s,21-trihydroxy-25-hydroperoxy-dammar-23-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyranosyl(1→3)]-α-l-arabi-nopyranosyl}-21-o-β-d-glucopyranoside |
|
C52H86O23 |
|
CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C(CCC6(C5(CCC4C3(C)C)C)C)C(CC=CC(C)(C)OO)(COC7C(C(C(C(O7)CO)O)O)O)O)C=O)O)OC8C(C(C(CO8)O)O)O)O)O)O |
|
TCMBANKIN014079 |
3β,20s,21-trihydroxydammar-24-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyranosyl(1→3)]-β-d-[6-o-acetylglucopyranosyl]}-21-o-β-d-glucopyranoside |
|
C55H92O22 |
|
|
|
TCMBANKIN015111 |
Gypenoside II |
gypenoside ii |
C60H102O26 |
1239.44 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C)(CCC=C(C)C)C3CCC4(C3C(CC5C4(CCC6C5(CCC(C6(C)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)C)C)O)C)O)O)O)O)O)O |
|
TCMBANKIN015225 |
Gypenoside XXXVI_qt |
Gypenosdie XXXVII_qt; Gypenoside XXXVII_qt |
C53H88O21 |
1061.25 |
|
|
TCMBANKIN015452 |
Gypentonoside A_qt |
|
C54H88O21 |
1073.26 |
|
|
TCMBANKIN015594 |
phosphatidylinositol |
1-Phosphatidyl-D-myo-inositol; Phosphatidylinositol; Phosphatidyl-1D-myo-inositol; 1-Phosphatidyl-1D-myo-inositol; Phosphatidylinositols, soya; 1-Phosphatidyl-myo-inositol; (3-Phosphatidyl)-1-D-inositol |
C11H19O13P |
390.23 g/mol |
C(C(COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O)OC=O)OC=O |
|
TCMBANKIN016349 |
Gypenoside XIV |
|
|
769.14 |
|
|
TCMBANKIN016403 |
3-o-beta-d-glucopyranosyl2alpha,3beta,12beta,20(S)-3hydroxy-dammarane24-ene20-o-beta-d-glucopyranoside |
|
|
801.14 |
|
|
TCMBANKIN016840 |
6""-malonylgypenoside v |
|
|
|
|
|
TCMBANKIN017059 |
Gypenoside LXXIII |
gypenoside lxxiii |
C48H82O17 |
931.15 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C)(CCC=C(C)C)C3CCC4(C3CCC5C4(CCC6C5(CC(C(C6(C)C)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)C)O)O)O)O)O)O |
|
TCMBANKIN017311 |
Gypinoside LXVII_qt |
|
|
476.82 |
|
|
TCMBANKIN017393 |
Gypenoside LIV |
gypenoside liv |
C41H70O13 |
770.99 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(CO5)O)O)OC6C(C(C(C(O6)CO)O)O)O)CO)C)O)C)O)C |
|
TCMBANKIN017486 |
Gypenoside LII_qt |
Gypenoside XLIX_qt |
C52H86O21 |
1047.23 |
|
|
TCMBANKIN017970 |
Gypenoside LXXIX |
gypenoside lxxix |
C42H72O13 |
785.01 |
CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)CO)C)C)OC6C(C(C(C(O6)CO)O)O)O)C |
|
TCMBANKIN017976 |
Gypenoside XXXV |
gypenoside xxxv |
C53H88O23 |
1093.25 |
CC(=CCCC(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C=O)C)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
|
TCMBANKIN018324 |
(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol |
(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol |
C42H72O14 |
801.01 |
|
|
TCMBANKIN018352 |
.alpha.-cis-bergamotene |
(Z)-trans-.alpha.-bergamotene; l-trans-.alpha.-Bergamotene; (1S,5S,7S)-4,7-dimethyl-7-(4-methylpent-3-enyl)bicyclo[3.1.1]hept-3-ene; bergamotene (Z,.alpha.,trans) |
C15H24 |
204.35 |
CC1=CCC2CC1C2(C)CCC=C(C)C |
|
TCMBANKIN019813 |
Gypenoside XIX2 |
|
|
1109.46 |
|
|
TCMBANKIN020193 |
Gypenoside XLI_qt |
|
C42H72O13 |
785.01 |
|
|
TCMBANKIN020512 |
Gypenoside LXVIII |
gypenoside lxviii |
C53H90O24 |
1111.27 |
|
|
TCMBANKIN020521 |
Gypenoside LXVIII_qt |
|
C53H90O24 |
1111.27 |
|
|
TCMBANKIN020734 |
Cyclobuxine |
CYCLOBUXINE-D; 9,19-Cyclo-5.alpha.,9.beta.-pregnan-16.alpha.-ol, 14-methyl-3.beta.,20.alpha.-bis(methylamino)-4-methylene-; 9,19-Cyclopregnan-16-ol, 14-methyl-3,20-bis(methylamino)-4-methylene-, (3.beta.,5.alpha.,16.alpha.,20S)-; Cyclobuxine D; C10797; NSC91720; 2241-90-9 |
C25H42N2O |
386.61 |
CC(C1C(CC2(C1(CCC34C2CCC5C3(C4)CCC(C5=C)NC)C)C)O)NC |
|
TCMBANKIN020751 |
(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol |
C53H90O22 |
1079.27 |
|
|
TCMBANKIN021082 |
Gypenoside XXIX |
gypenoside xxix |
C41H68O12 |
752.97 |
CC(=CCCC(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(CO5)O)O)OC6C(C(C(C(O6)CO)O)O)O)C=O)C)C)O)C |
|
TCMBANKIN021099 |
5-methylhydantoin |
NCGC00179379-02; NCGC00179379-01; 40856-73-3; FCH951677; Methylhydantoin-5-(L); Prestwick2_000860; Prestwick_215; SPBio_002800; (l)-5-methylhydantoin; HMS1570L21; CHEBI:94659; BRD-K56033645-001-01-8; VMAQYKGITHDWKL-REOHCLBHSA-N; (5S)-5-Methylhydantoin; Prestwick1_000860; BPBio1_000999; 5-methyl hydantoin; DTXSID70423560; ZINC1701819; Prestwick0_000860; L16M035; (S)-5-METHYLHYDANTOIN; SCHEMBL8110002; FT-0671818; HMS3714L21; (5S)-5-methylimidazolidine-2,4-dione; L-5-METHYLHYDANTOIN; ACM40856733; (S)-5-methylimidazolidine-2,4-dione; CJ-28736; AC1O4WGH; HMS2097N09; HMS2097L21; CCG-220860; BPBio1_000967; Prestwick3_000860; Prestwick3_000864; BSPBio_000879; BSPBio_000907 |
C4H6N2O2 |
114.1 g/mol |
CC1C(=O)NC(=O)N1 |
|
TCMBANKIN021220 |
4-amino-5-ethoxyimidazole |
|
|
127.17 |
|
|
TCMBANKIN021369 |
Gypenoside LXXIV |
gypenoside lxxiv |
C42H72O14 |
801.01 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)CO)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C |
|
TCMBANKIN021486 |
2-ethylidene-1,1-dimethyl-cyclopentane |
|
C9H16 |
124.22 |
CC=C1CCCC1(C)C |
|
TCMBANKIN021531 |
Onjisaponin F |
onjisaponin f |
C75H112O36 |
1589.67 |
CC1C(C(C(C(O1)OC(=O)C23CCC(CC2C4=CCC5C(C4(CC3)CO)(CCC6C5(CC(C(C6(C)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)(C)C)OC8C(C(C(C(O8)C)OC9C(C(C(CO9)O)OC1C(C(C(CO1)O)O)O)O)OC1C(C(CO1)(CO)O)O)O)O)OC(=O)C=CC1=CC(=C(C(=C1)OC)OC)OC |
|
TCMBANKIN021781 |
Gypenoside XL_qt |
Gypenoside LIII_qt |
C41H68O13 |
768.97 |
|
|
TCMBANKIN022884 |
3β,12β,23s,24r-tetrahydroxy-20s,25-epoxy-dammarane 3-o-[β-d-xylopyranosyl(1→2)]-β-d-glucopyranoside |
|
C41H70O14 |
|
|
|
TCMBANKIN022946 |
Gypenoside XVIII |
gypenoside xviii |
|
933.27 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)CO)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)O)O)O)O)C)O)C)C)O)O)O)O)O)O |
|
TCMBANKIN022980 |
caprylic acid |
Octanoic acid (mixed isomers); AK405365; octoic acid; Sodium octanoate, 96%; Natrium octanoat; D05220; NoO notEa AAENI; W279927_ALDRICH; Sodium caprylate [NF]; KB-80641; ACMC-1BO0W; MCULE-8227046407; AIDS-006110; Caprylsaeure; V0353; Octylic acid; Enantic acid; Caprylic acid sodium salt; Sodium n-octanoate; Sodium octoate; Octanoic acid sodium salt; 68937-74-6; MolPort-006-113-836; EINECS 273-085-7; C-8 acid; 21639_FLUKA; HSDB 5862; AIDS006110; NCGC00090957-02; 0ctanoic acid; BYKRNSHANADUFY-UHFFFAOYSA-M; Acid C-8; caprylic acid, sodium salt; 124-07-2; Acido octanoico [Spanish]; Sodium octanoate, 96% 100g; Octic acid; 124-07-2 (Parent); W279900_ALDRICH; KS-00000YJH; capryloate; Sodium caprylate: Octanoic acid; NCGC00090957-01; Acide octanoique [French]; Sodium caprylate (NF); O0034; UNII-9XTM81VK2B; LS-98001; 18312-04-4; neo-fat 8; OCTANOIC ACID (CAPRYLIC ACID); SODIUM OCTANOATE; 1-heptanecarboxylic acid; NCIOpen2_009358; LS-691; O3907_ALDRICH; 1984/6/1; CHEBI:132100; MFCD00058511; AN-19785; ANW-13619; NCIOpen2_002902; octanoic acid; C2875_SIGMA; I14-14709; TR-009215; Caprylic acid (natural); NSC 5024; CHEBI:28837; Octanoic acid [USAN:INN]; LMFA01010008; n-octylic acid; TRA-0206488; Fatty acids, C6-1O; FEMA No. 2799; BRN 1747180; 4-02-00-00982 (Beilstein Handbook Reference); 9XTM81VK2B; EINECS 204-677-5; CHEMBL557076; Octanoic acid, sodium salt; EINECS 217-850-5; ST51037190; KSC490S9T; caprylic acid ; NSC5024; AI3-50473; SCHEMBL56211; Sodium Salt of Caprylic Acid; Octanoic acid (USAN); Hexacid 898; CH3-[CH2]6-COOH; Sodium caprylate; Sodium caprylate [USAN]; RTR-009215; 27633_RIEDEL; Kaprylsaeure; C06423; Fatty acids, C6-10; caprylicacid; Acidum octanocium [Latin]; HSDB 821; AI3-04162; Kyselina kaprylova [Czech]; n-octanoic acid; FT-0701289; n-caprylic acid; AS-17478; CCRIS 4689; PubChem12870; 21650_FLUKA; n-Octoic acid; W-109735; CTK3J0999; AKOS015901906; OCA; Octansaeure; SC-79959; n-Octanoic Acid Sodium Salt; WLN: QV7; CPD-195; Octanoic acid, sodium salt (1:1); DTXSID3027451; D08999 |
C8H16O2 |
144.21 g/mol |
CCCCCCCC(=O)O |
|
TCMBANKIN023449 |
gynosaponin TN-1 |
|
C36H62O9 |
638.87 |
|
|
TCMBANKIN023744 |
Gypenoside LVIII_qt |
|
C52H88O21 |
1049.24 |
|
|
TCMBANKIN023914 |
Gypenoside LXI_qt |
Gypenoside LIX_qt |
C41H70O14 |
786.99 |
|
|
TCMBANKIN023990 |
Gypenoside XVIII_qt |
|
|
446.79 |
|
|
TCMBANKIN024362 |
Gypenoside LIII |
gypenoside liii |
|
769.09 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(CO5)O)O)OC6C(C(C(C(O6)CO)O)O)O)C=O)C)O)C)O)C |
|
TCMBANKIN024503 |
1-isochromanone |
isochroman-1-one; 4702-34-5; 3,4-Dihydro-1H-2-benzopyran-1-one; EINECS 225-179-4; Dihydroisocoumarin; 3,4-Dihydro-1H-isochromen-1-one; 1H-2-Benzopyran-1-one, 3,4-dihydro- |
C9H8O2 |
148.16 |
C1COC(=O)C2=CC=CC=C21 |
|
TCMBANKIN024707 |
Gypenoside XXVI |
gypenoside xxvi |
|
901.22 |
CC(=CCCC(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(CO5)O)O)OC6C(C(C(C(O6)CO)O)O)O)C=O)C)C)OC7C(C(C(C(O7)CO)O)O)O)C |
|
TCMBANKIN024737 |
Gypenoside XLIV |
gypenoside xliv |
|
933.27 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)C |
|
TCMBANKIN024804 |
Gypenoside XX_qt |
Gypenoside XIX2_qt; Gypenoside XXI_qt; Gypenoside LXX_qt |
C60H102O28 |
1271.44 |
|
|
TCMBANKIN024892 |
(2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12, |
(2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentame; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pent |
C48H82O18 |
947.15 |
|
|
TCMBANKIN024915 |
Gypenoside LX_qt |
Gypenoside LXXVIII_qt |
C41H70O14 |
786.99 |
|
|
TCMBANKIN025102 |
gynsenoside Rd_qt |
|
|
460.82 |
|
|
TCMBANKIN025342 |
Gypenoside XIV_qt |
ginsenoside rb3_qt; Notoginsenoside Fe_qt |
C42H72O12 |
769.01 |
|
|
TCMBANKIN025358 |
benzoic acid |
Benzoic acid, 2-[(carboxymethyl)amino]-4-chloro-; 2-[(carboxymethyl)amino]-4-chlorobenzoic acid; DTXSID70455462; BG00311790; AC-17987; AX8062950; 2-carboxymethylamino-4-chlorobenzoic acid; KB-223858; AK140629; 99282-79-8; benzoicacid; CTK5I0315; 2-(Carboxymethyl-amino)-4-chloro-; AKOS015963713; SCHEMBL3236365; 2-(carboxymethylamino)-4-chlorobenzoic acid; benzoic acid ; 2-(CARBOXYMETHYL-AMINO)-4-CHLORO-BENZOIC ACID; AJ-79604; 2-((Carboxymethyl)amino)-4-chlorobenzoic acid; UDXGKLGUAJLLCJ-UHFFFAOYSA-N; ZINC21988796 |
C7H6O2 |
122.12 |
C1=CC(=C(C=C1Cl)NCC(=O)O)C(=O)O |
|
TCMBANKIN025412 |
Gypenoside LXII |
gypenoside lxii |
|
1095.43 |
|
|
TCMBANKIN025475 |
Gypenoside L_qt |
Gypenoside XLVII_qt; Gypenoside LXVI_qt; Gypenoside XLV_qt; Gypenoside XLIII_qt; Gypenoside XLVI_qt; Gypenoside XLIV_qt; Gypenoside LVI_qt; Gypenoside XLII_qt; Gypenoside LVII_qt; Gypenoside LXXVII_qt |
C54H92O24 |
1125.29 |
|
|
TCMBANKIN025526 |
Gypenoside LXXV |
gypenoside lxxv |
C42H72O13 |
785.01 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(C(O6)CO)O)O)O)O)O)O)C |
|
TCMBANKIN025892 |
Gypenoside LXXIII_qt |
|
C48H82O17 |
931.15 |
|
|
TCMBANKIN026249 |
Gypenoside LVIII |
gypenoside lviii |
C52H88O21 |
1049.24 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(CO5)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
|
TCMBANKIN026497 |
gynosaponin TN-1_qt |
|
C36H62O9 |
638.87 |
|
|
TCMBANKIN027341 |
Gypenoside LXIII |
gypenoside lxiii |
|
1079.43 |
CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)CO)C)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
|
TCMBANKIN027682 |
Gypenoside XXV_qt |
|
C47H78O18 |
931.11 |
|
|
TCMBANKIN028948 |
3-o-beta-d-glucopyranosyl2alpha,3beta,12beta,20(S)-3hydroxy-dammarane24-ene20-o-beta-d-glucopyranoside_qt |
|
|
476.82 |
|
|
TCMBANKIN029140 |
Gypenoside XLV |
gypenoside xlv |
C48H82O18 |
947.15 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C)(CCC=C(C)C)C3CCC4(C3C(CC5C4(CCC6C5CCC(C6(C)C)OC7C(C(C(C(O7)CO)O)O)O)C)O)C)O)O)O)O)O)O |
|
TCMBANKIN029303 |
Rhamnazin |
3,5-dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-chromone; AIDS-147836; 3,5-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-4H-chromen-4-one; NSC678106; 3,5-dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-7-methoxy-chromen-4-one; 4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-; NCI60_027977; AIDS147836; 3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxychromen-4-one; 552-54-5; Flavone, 3,4',5-trihydroxy-3',7-dimethoxy-; 3,5,4'-Trihydroxy-7,3'-dimethoxyflavone; rhamnazin; 3',7-Dimethylquercetin; 3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-4-chromenone |
C17H14O7 |
330.29 |
COC1=CC(=C2C(=C1)OC(=C(C2=O)O)C3=CC(=C(C=C3)O)OC)O |
|
TCMBANKIN029493 |
Gypenoside XXX_qt |
Gypenoside XXXI_qt; Gypenoside XXII_qt |
C53H90O23 |
1095.27 |
|
|
TCMBANKIN029502 |
Gypenoside XXX |
gypenoside xxx |
|
771.11 |
CC(=CCCC(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)CO)C)C)OC6C(C(C(C(O6)CO)O)O)O)C |
|
TCMBANKIN029534 |
Gypenoside LV |
gypenoside lv |
C47H80O17 |
917.13 |
CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)CO)C)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)O)O)O)O)C |
|
TCMBANKIN029737 |
Gypentonoside A |
gypentonoside a |
C54H88O21 |
1073.26 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC(=O)C6C5(CCC6C(C)(CC(=O)C=C(C)C)O)C)C)C)OC7C(C(C(C(O7)C)O)O)O)OC8C(C(C(C(O8)C)O)O)O)O)O)O)O |
|
TCMBANKIN030343 |
cucurbita-5,24-dienol |
|
|
440.83 |
|
|
TCMBANKIN030396 |
Gypenoside XXI |
gypenoside xxi |
C41H70O13 |
770.99 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)CO |
|
TCMBANKIN030794 |
6""-malonylginsenoside rd1 |
|
|
|
|
|
TCMBANKIN031112 |
19-oxo-3β,20s,21,24s-tetrahydroxydammar-25-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyranosyl(1→3)]-α-l-arabinopyranosyl}-21-o-β-d-glucopyranoside |
|
C52H86O22 |
|
CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C(CCC6(C5(CCC4C3(C)C)C)C)C(CCC(C(=C)C)O)(COC7C(C(C(C(O7)CO)O)O)O)O)C=O)O)OC8C(C(C(CO8)O)O)O)O)O)O |
|
TCMBANKIN031194 |
Ruvoside_qt |
|
C30H46O9 |
550.68 |
|
|
TCMBANKIN031295 |
3β,19α,23-trihydroxy-6-oxo-olean-12-en-28-oicacid |
|
C30H46O6 |
|
|
|
TCMBANKIN031470 |
gypenosideix |
Gypenoside IX; gypenoside ix |
C47H80O17 |
917.13 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)O)O)O)O)C |
|
TCMBANKIN031700 |
gynsenoside Rd |
|
|
947.3 |
|
|
TCMBANKIN031758 |
Gypenoside III_qt |
|
C54H92O23 |
1109.29 |
|
|
TCMBANKIN032065 |
Gypnoside V |
gypnoside v |
|
1093.46 |
|
|
TCMBANKIN032096 |
triterpenoidsaponin |
triterpenoid saponin |
|
767.07 |
CC1C2C(C(C(O1)OC3C(C(COC3OC(=O)C45CCC(CC4(C6=CCC7(C(C6(CC5)C)(CCC8C7(CC(C(C8(C)CO)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)C(=O)CC(CC(=O)O2)(C)O)O)O)O)O)C)C)C)C)(C)C)O)O)O)OC1C(C(C(CO1)O)O)O |
|
TCMBANKIN032999 |
phosphatdic acid |
phosphatidylinositol_qt; AC1NUST0; (2-formyloxy-3-phosphonooxypropyl) formate |
|
228.11 |
|
|
TCMBANKIN033362 |
Gypenoside LXX |
gypenoside lxx |
|
1095.43 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)CO |
|
TCMBANKIN033690 |
2,4-dimethyl-6-(3'-m ethyl-isobuten-5'-iso-propyl)-phenyl-3,5-hexanedione |
|
C22H32O2 |
|
|
|
TCMBANKIN033692 |
Gypenoside LI |
gypenoside li |
C42H72O14 |
801.01 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CC(C(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)O)C)O)C |
|
TCMBANKIN033920 |
phosphatidylcholine |
phosphatidyl choline |
|
314.29 |
CCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC |
|
TCMBANKIN033935 |
Malonylginsenoside Rd_qt |
Malonylginsenoside Rd_qt1 |
|
460.82 |
|
|
TCMBANKIN034276 |
3β,20s,21-trihydroxydammar-24-ene 3-o-{[α-l-rhamnopyranosyl(1→2)][β-d-xylopyranosyl(1→3)]-β-d-glucopyranosyl}-21-o-β-d-glu-copyranoside |
|
C53H90O21 |
|
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC4(C5CCC6C(CCC6(C5(CCC4C3(C)C)C)C)C(CCC=C(C)C)(COC7C(C(C(C(O7)CO)O)O)O)O)C)CO)O)OC8C(C(C(CO8)O)O)O)O)O)O |
|
TCMBANKIN034288 |
ZINC01680040 |
(3R)-non-1-en-3-ol |
|
142.27 |
|
|
TCMBANKIN034578 |
3β,12-dihydroxy-13-methyl-5,8,11,13-podocar-patetraen-7-one |
|
C18H22O3 |
|
CC1=C(C=C2C(=C1)C(=O)C=C3C2(CCC(C3(C)C)O)C)O |
|
TCMBANKIN034592 |
Gypenoside VIII_qt |
|
C48H82O18 |
947.15 |
|
|
TCMBANKIN034784 |
Gypenoside LVI |
gypenoside lvi |
C53H90O23 |
1095.27 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CC(C(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
|
TCMBANKIN034808 |
beta-D-arabinopyranose |
ZINC01532588; CHEBI:46996; (2R,3S,4R,5R)-tetrahydropyran-2,3,4,5-tetrol; (2R,3S,4R,5R)-oxane-2,3,4,5-tetrol |
C5H10O5 |
150.13 |
C1C(C(C(C(O1)O)O)O)O |
|
TCMBANKIN034891 |
GLO |
Glucose (C-14); maltodextrin; 815-92-9; (C13)D-Glucose; D-(U-14C)Glucose; Glucose (C-13); aldehydo-D-gluco-hexose; CHEBI:42758; EINECS 224-118-9; (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal; D-GLUCOSE IN LINEAR FORM; ZINC02043211; 28823-03-2; 9050-36-6; D-Glucose, labeled with carbon-14; aldehydo-D-glucose; D-Glucose, labeled with carbon-13; (U-14C)Glucose; D-Glucose, labeled with tritium; (14C)-Glucose; 19030-38-7; (14C)D-Glucose |
C6H12O6 |
192.11 g/mol |
C(C(C(C(C(C=O)O)O)O)O)O |
|
TCMBANKIN035034 |
Gypenoside LXV |
gypenoside lxv |
C41H70O13 |
770.99 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)CO)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)C |
|
TCMBANKIN035144 |
Gypenoside VII |
gypenoside vii |
C54H92O21 |
1077.3 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)O)O)O)O)C)O)C)C)O)O)O)O)O)O |
|
TCMBANKIN035576 |
ZINC00407077 |
|
C9H14N2O |
166.22 |
|
|
TCMBANKIN035743 |
Gypenoside XXXII_qt |
|
C42H72O14 |
801.01 |
|
|
TCMBANKIN036114 |
Gypenoside LXXVII |
gypenoside lxxvii |
|
741.08 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3CCC(C4(C)C)O)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)C |
|
TCMBANKIN036283 |
3β,12β,23s,24r-tetrahydroxy-20s,25-epoxy-dammarane 3-o-[β-d-glucopyranosyl(1→2)][β-d-xylopyranosyl-(1→6)]-β-d-glucopyrano-side |
|
C47H80O19 |
|
|
|
TCMBANKIN036298 |
23-o-acetyl-3β,12β,23s,24r-tetrahydroxy-20s,25-epoxydammarane 3-o-[β-d-xylopyra-nosyl(1→2)][β-d-xylopyranosyl(1→6)]-β-d-glucopyranoside |
|
C48H80O19 |
|
CC(=O)OC1CC(OC(C1O)(C)C)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)O)O)O)OC8C(C(C(CO8)O)O)O)C)C)O)C |
|
TCMBANKIN036502 |
2α,3β,13β-trihydroxyurs-11-en-28-oic acid |
|
|
504.78 |
|
|
TCMBANKIN036873 |
Ginsenoside Rd |
ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6 |
|
947 |
|
|
TCMBANKIN037034 |
gynosaponin tn1 |
|
C36H62O9 |
|
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CC(C(C4(C)C)O)O)C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C |
|
TCMBANKIN037647 |
Gypeniside LII |
|
C47H78O18 |
|
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[H])(C([H])([H])O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])
O[H])O2)C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])
[H])[C@]1([H])O[C@]6([H])[C@]([H])(O[C@@]7([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O7)[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])O6 |
|
TCMBANKIN038167 |
24alpha-ethyl-5alpha-cholestan-3beta-ol |
24α-ethyl-5α-cholestan-3β-ol |
C29H52O |
416.72 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])(C([
H])([H])[H])C([H])([H])[H])C([H])([H])C2([H])[H])[C@]23[H])[C@@]3([H])C([H])([H])C4([H])[H])[C@]4([H])C([H])([H])[C@@]1([H])O[H] |
|
TCMBANKIN038189 |
gypenoside XVII |
Gypenoside XVII; gypenosidexvii; gypenosideXVII |
C48H82O18 |
947 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@]([H])(O[C@]([H])(C([H])([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]2([H])O[H])[C@](
[H])(O[H])[C@@]2([H])O[H])[C@@]3([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@
@]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]7([H])O[H])[C@]([H])(O[H])[C@@]7([H])O[H] |
|
TCMBANKIN038218 |
Gypenosdie XXXVII |
|
C53H88O22 |
|
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@]3([H])[C@]([H])(O
[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O3)O2)(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C([H])([H])[H])C(
[H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]7([H])[C@]([H])(O[C@@]8([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O8)[C@@]([H])(O[H])
[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O7 |
|
TCMBANKIN038369 |
20(R)-21,24-Cyclo-3beta,25-dihydroxyl-dammar-23(24)-en-21-one |
20(r)-21,24-cyclo-3β,25-dihydroxyldammar-23(24)-en-21-one |
C30H48O3 |
|
[C@]1([H])(O[H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@]2([H])C([H])([H])C([H])=C(C(C([H])([H])[H])(C([H])([H])[H])O[H])C2=O)C([H])([H])C3
([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C1(C([H])([H])[H])C([H])([H])[H] |
|
TCMBANKIN038635 |
Ombuoside |
|
|
638.63 |
|
|
TCMBANKIN038640 |
Gypinoside VII |
gypinoside vii |
|
1077.46 |
|
|
TCMBANKIN039128 |
Isofucosterol |
C08812; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methylhex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; C08821; AIDS113090; 481-14-1; isofucosterol; (3S,8S,9S,10R,13R,14S,17R)-17-[(Z,1R)-4-isopropyl-1-methyl-hex-4-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; AIDS-113090; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 18472-36-1; delta5-Avenasterol |
C29H48O |
412.69 |
CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN039545 |
gypsogenin |
BUOYQGLRFDDTLB-KBIKRTHESA-N; Saponin-gypsophila; Albsapogenin; Gypsogenin; 3-Hydroxy-23-oxo-olean-12-en-28-oic acid, (3-beta,4-alpha)- (9CI); CHEBI:5580; 3beta-hydroxy-23-oxoolean-12-en-28-oic acid; C08950; Olean-12-en-28-oic acid, 3-beta-hydroxy-23-oxo-; Githagenin; CHEMBL261695; (3beta,4alpha)-3-Hydroxy-23-oxoolean-12-en-28-oic acid; 639-14-5; Gypsophilasapogenin; (4aS,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-9-formyl-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; EINECS 211-353-7; Gypsophila paniculata saponin (swiss standard saponin); Gypsophilasaponin; (4aS,6aR,6aS,6bR,8aR,9S,10S,12aR,14bS)-10-hydroxy-9-methanoyl-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; Astrantiagenin D |
C30H46O4 |
470.7 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C=O)O)C)C)C2C1)C)C(=O)O)C |
|
TCMBANKIN039821 |
Gypinoside LXVII |
gypinoside lxvii |
|
1095.43 |
|
|
TCMBANKIN039848 |
Gypenoside L |
gypenoside l |
C42H72O14 |
801.01 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)O)C |
|
TCMBANKIN039930 |
Gypenoside LXI |
gypenoside lxi |
C52H88O23 |
1111.27 |
C1([H])([H])C([H])([H])[C@@]([H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@]3([H])[C@]([H])(O
[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O3)O2)(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])O[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C([H])([H])[H])C
([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]7([H])[C@]([H])(O[C@@]8([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O8)[C@@]([H])(O[H]
)[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O7 |
|
TCMBANKIN040840 |
24,24-Dimethyl-5alpha-cholesta-8-en-3beta-ol |
24,24-dimethyl-5α-cholesta-8-en-3β-ol; AC1NSUUM; (3S,10S,13R)-10,13-dimethyl-17-(5,5,6-trimethylheptan-2-yl)-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
C29H50O |
414.7 g/mol |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C2([H])[H])[C@]2(
[H])C(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(O[H])C([H])([H])C3([H])[H])[C@]34C([H])([H])[H])=C14 |
|
TCMBANKIN040956 |
Gypenoside XXXVII |
gypenoside xxxvii; Gypenosdie XXXVII |
|
1047.2 g/mol |
|
|
TCMBANKIN041154 |
gypenoside LXIX |
Ginsenoside-Rb3; gypenoside lxix |
C53H90O24 |
1111 |
[C@]1([H])(O[H])C([H])([H])O[C@@]([H])(OC([H])([H])[C@@]([H])(O[C@@]([H])(O[C@@]([C@@]2([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@]([H])(C(C([H])([H
])[H])(C([H])([H])[H])[C@@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]4([H])O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(C([H])([H])O[H])O3
)[C@]([H])(O[H])C5([H])[H])[C@]56C([H])([H])[H])[C@@]6([H])C([H])([H])[C@@]7([H])O[H])[C@@]27[H])(C([H])([H])[H])C([H])([H])\C([H])=C([H])\C(O[H])(C([H])([H])[H])C([H])([H])[H])[C@]([H])(O[H])[C@@]8([
H])O[H])[C@@]8([H])O[H])[C@]([H])(O[H])[C@@]1([H])O[H] |
|
TCMBANKIN041272 |
stearic acid |
4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 |
C18H36O2 |
284 |
C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=
O |
|
TCMBANKIN041704 |
Cyclobuxine D |
cyclobuxine-d |
|
386.6 g/mol |
|
|
TCMBANKIN042012 |
gypenoside LXXI |
gypenoside lxxi |
C53H90O23 |
1095 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@]([H])(O[C@]2([H])C([H])([H])O[C@]([H])(OC3([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3
([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[H])C(C([H])([H])[H])=C([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C([H])([H])[
H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@]([H])(O[C@]7([H])C([H])([H])O[H])[C@]([H])(O[C@]([H])(O[C@]8([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@
]8([H])O[H])[C@@]([H])(O[H])[C@]7([H])O[H] |
|
TCMBANKIN042276 |
Gypenoside XXIV |
gypenoside xxiv |
C47H78O18 |
961.14 |
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@@](O[H])([C@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)C([H])([H
])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C
@@]6([H])[C@]([H])(O[C@@]7([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O7)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6 |
|
TCMBANKIN043278 |
Ombuin |
NSC 675952; BDBM50240614; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4H-1-benzopyran-4-one; kaempferol-7,4'-dimethylether; 3,5-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromone; CHEMBL75589; FLAVONE, 4',7-DIMETHOXY-3,3',5-TRIHYDROXY-; Quercetin 4',7-dimethyl ether; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4H-chromen-4-one; Quercetin-7,4'-Dimethyl Ether; CHEBI:67493; AC1NSZAJ; DTXSID00200942; MolPort-039-338-131; LS-68977; Ambap529-40-8; Z3K3F0YR3W; CJ-26550; AIDS-071739; NSC-675952; NSC675952; ombuin; CTK8J0348; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxychromen-4-one; OMBUINE; 3,5,3'-Trihydroxy-7,4'-dimethoxyflavone; 4',7-Dimethoxy-3,3',5-trihydroxyflavone; 4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-; 529-40-8; ZINC1645590; 4',7-Dimethylquercetin; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4-chromenone; LMPK12112652; 5-18-05-00498 (Beilstein Handbook Reference); quercetin 7,4'-dimethyl ether; UNII-Z3K3F0YR3W; 7,4'-dimethylquercetin; AIDS071739; BRN 0338215; 4'',7-dimethylquercetin; ST24041236; 3,5-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromen-4-one; quercetin-7,4''-dimethyl ether; 7,4'-Di-O-methylquercetin; 3,5-Dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromen-4-one; SCHEMBL1252211 |
C17H14O7 |
330.29 |
COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)OC)O)O)O |
|
TCMBANKIN043341 |
Gypinoside III |
gypinoside iii |
C54H92O23 |
1109.46 |
[C@]1([H])(O[C@@]2([H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O3)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)C([H])([H])C([H])(
[H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@@]([H])([C@]([H])(O[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C(
[H])([H])O[H])O4)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]5([H])C([H])([H])O[H])O5)C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]67C([H])([H])[H])[C@@]7(C([H])(
[H])[H])C([H])([H])C8([H])[H])[C@@]8([H])C1(C([H])([H])[H])C([H])([H])[H] |
|
TCMBANKIN043344 |
Gypenoside XXVIII |
gypenoside xxviii |
C39H64O13 |
783 g/mol |
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@]([H])(O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2
3C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C([H])([H])[C@]1([H])O[C@@]5([H])[C@]([H])(O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O
6)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5 |
|
TCMBANKIN043368 |
14alpha-Methyl-5alpha-ergosta-9(11),24(28)-dien-3beta-ol |
14α-methyl-5α-ergosta-9(11),24(28)-dien-3β-ol |
C29H48O |
412.7 g/mol |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=C([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@@]([H])(C([H])([H])C([H])([H])C(C([H])(C([H])([H])[H])C([H])([H])[H])=C([H])[H])C([H])([H])[H])C([H])
([H])C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3([H])C([H])([H])C4([H])[H])[C@]4([H])C([H])([H])[C@@]1([H])O[H] |
|
TCMBANKIN043687 |
Gypenoside XV |
gypenoside xv |
C52H88O21 |
1049.24 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(CO8)O)O)O)C |
|
TCMBANKIN043861 |
6''-Malonylgypenoside V |
|
|
|
|
|
TCMBANKIN043927 |
6-O-malonyl-beta-methyl-D-glucopyranoside |
3-oxo-3-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methoxy]propanoic acid; 3-oxo-3-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxy-oxan-2-yl]methoxy]propanoic acid; 3-keto-3-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxy-tetrahydropyran-2-yl]methoxy]propionic acid; 3-oxo-3-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxy-2-tetrahydropyranyl]methoxy]propanoic acid; 3-oxo-3-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxy-tetrahydropyran-2-yl]methoxy]propanoic acid; 6-o-malonyl-β-methyl-d-glucopyranoside; 6-o-malonyl-beta-methyl-d-glucopyranoside |
|
280.26 |
COC1C(C(C(C(O1)COC(=O)CC(=O)O)O)O)O |
|
TCMBANKIN044088 |
Gypenoside LII |
gypenoside lii |
|
931.25 |
|
|
TCMBANKIN044833 |
gynoside b |
|
C42H72O14 |
801 g/mol |
CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C7(CCC(O7)C(C)(C)O)C)C)O)C)C |
|
TCMBANKIN044884 |
Gypenoside XL |
gypenoside xl |
C42H70O14 |
799.12 |
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])
C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]5([H])[C@]([H])(O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]
([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5 |
|
TCMBANKIN044892 |
Gypenoside XXVII |
gypenoside xxvii |
C39H66O13 |
785.01 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])O[H])([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@]([H])(O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C2([H])[H]
)[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C([H])([H])[C@]1([H])O[C@@]5([H])[C@]([H])(O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H]
)O[H])O6)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5 |
|
TCMBANKIN045391 |
Gypenoside V |
|
|
|
|
|
TCMBANKIN045662 |
Gypenoside IV |
gypenoside iv |
C53H90O22 |
1079.27 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H]
)([H])O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O3)O2)C([H])([H])C([H])([H])\C(=C(/C([H])([H])[H])\C([H])([H])[H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C([H
])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]7([H])[C@]([H])(O[C@@]8([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O8)[C@
@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O7 |
|
TCMBANKIN045781 |
Gypenoside XXXII |
gypenoside xxxii |
C41H70O14 |
801.01 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])O[H])([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@@](O[H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)
C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]
1([H])O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6 |
|
TCMBANKIN045936 |
Gypenoside XVI |
gypenoside xvi |
C53H90O21 |
1063.27 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]3([H]
)[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O3)O2)(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H
])[C@@]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]7([H])[C@]([H])(O[C@]8([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])C([H])([H])O8)[C@@]([
H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O7 |
|
TCMBANKIN046226 |
Gypenoside XLIX |
gypenoside xlix |
C52H86O21 |
1047.23 |
CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C(CCC6(C5(CCC4C3(C)C)C)C)C(CCC=C(C)C)(COC7C(C(C(C(O7)CO)O)O)O)O)C=O)O)OC8C(C(C(CO8)O)O)O)O)O)O |
|
TCMBANKIN046276 |
Gynoside C |
|
|
771 g/mol |
|
|
TCMBANKIN046339 |
14alpha-Methyl-5alpha-ergosta-9(11)-en-3beta-ol |
14alpha-methyl-5alpha-ergosta-9(11)-en-3beta-ol; 14α-methyl-5α-ergosta-9(11)-en-3β-ol |
C29H50O |
414.7 g/mol |
CC(C)C(C)CCC(C)C1CCC2(C1(CC=C3C2CCC4C3(CCC(C4)O)C)C)C |
|
TCMBANKIN046454 |
gypenoside XLVIII |
gypenosidexlviii |
C53H88O22 |
1077 |
O([C@@]1([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H])C([H])([H])[C@]([C@@]2([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H]
)[C@]([H])(C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(O[C@@]3([H])[C@]([H])(O[C@]([H])(O[C@@]4([H])C([H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(O[C@@]5([H])[C@]([H])(O[H])[
C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5)[C@@]([H])(O[H])C([H])([H])O3)C([H])([H])C6([H])[H])[C@]67C([H])=O)[C@@]7([H])C([H])([H])C8([H])[H])[C@@]28[H])(O[H])C([H])([H])C([H])([H])\
C([H])=C(/C([H])([H])[H])\C([H])([H])[H] |
|
TCMBANKIN047197 |
gynoside e |
|
C41H68O13 |
769 g/mol |
CC1(C2CCC3(C(C2(CCC1OC4C(C(C(CO4)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC6C7C3(CCC7C8(CCC(O6)(O8)C(C)(C)O)C)C)C)C |
|
TCMBANKIN047248 |
3β,21α-dihydroxyserrat-14-en-24-ol |
|
C30H50O3 |
|
|
|
TCMBANKIN047835 |
Gypenoside XXXI |
gypenoside xxxi |
C42H72O14 |
801.01 |
CC(=CCCC(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)CO)C)C)O)C |
|
TCMBANKIN048020 |
Gypenoside XXV |
gypenoside xxv |
C47H78O18 |
931.11 |
CC(=CCCC(COC1C(C(C(C(O1)CO)O)O)O)(C2CCC3(C2CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)OC7C(C(C(C(O7)CO)O)O)O)C=O)C)C)O)C |
|
TCMBANKIN048036 |
gynoside d |
|
C41H70O14 |
787 g/mol |
CC1(C2CCC3(C(C2(CCC1OC4C(C(C(CO4)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C7(CC(C(O7)C(C)(C)O)O)C)C)O)C)C |
|
TCMBANKIN048047 |
Gypenoside LXVI |
gypenoside lxvi |
C41H70O12 |
785.01 |
C1([H])([H])C([H])([H])[C@@]([H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]3([H])[C@]([H])(
O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O3)O2)(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C(
[H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H] |
|
TCMBANKIN048518 |
7-(6-O-Malony-beta-D-glucopyransyloxy)-3-(4-hydroxphenyl)-4H-1-benzopyran-4-one |
7-(6-o-malony-beta-d-glucopyransyloxy)-3-(4-hydroxphenyl)-4h-1-benzopyran-4-one |
C24H24O12 |
504.44 |
C(O[H])(C([H])([H])C(OC([H])([H])[C@@]1([H])O[C@]([H])(Oc2c([H])c(OC([H])([H])[C@]([H])(c3c([H])c([H])c(O[H])c([H])c3[H])C4=O)c4c([H])c2[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H])=O)=O |
|
TCMBANKIN048652 |
Gypenoside VI |
gypenoside vi |
C54H92O22 |
1093.3 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)(C(
[H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])
([H])[H])[C@]1([H])O[C@@]6([H])[C@]([H])(O[C@@]7([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]8([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])
[H])O8)O7)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6 |
|
TCMBANKIN048819 |
Gypenoside XXXIII |
gypenoside xxxiii |
C41H68O13 |
799 |
C1([H])([H])C([H])([H])[C@@](C([H])=O)([C@@]([H])(C([H])([H])C([H])([H])[C@]([H])([C@@]([H])([C@@]([H])(O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]
23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]5([H])[C@]([H])(O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]
([H])(C([H])([H])O[H])O6)[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5 |
|
TCMBANKIN049464 |
gynoside a |
|
C41H70O13 |
771 g/mol |
CC1(C2CCC3(C(C2(CCC1OC4C(C(C(CO4)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C7(CCC(O7)C(C)(C)O)C)C)O)C)C |
|
TCMBANKIN049485 |
Gypenoside LXVII |
|
|
|
|
|
TCMBANKIN049632 |
malonylawobanin |
Delphinidin 3-(6''-(E)-p-coumaroylglucoside)-5-(6''-malonylglucoside); malonyl awobanin; Malonylawobanin; LMPK12010299 |
C39H39O22+ |
859.7 g/mol |
C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=C([O+]=C4C=C(C=C(C4=C3)OC5C(C(C(C(O5)COC(=O)CC(=O)O)O)O)O)O)C6=CC(=C(C(=C6)O)O)O)O)O)O)O |
|
TCMBANKIN050141 |
Gypenoside XI |
gypenoside XI; gypenoside xi |
C48H82O17 |
931.15 |
C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)(C(
[H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])
([H])[H])[C@]1([H])O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]7([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O7)O6 |
|
TCMBANKIN050210 |
Gypenoside VIII |
gypenoside viii |
C48H82O18 |
947.15 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
|
TCMBANKIN057922 |
malonicacid |
malonic acid; MLI; AI3-15375; C00383; DICARBOXYLIC ACID C3; InChI=1/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7; Dicarboxylate; PROPANEDIOIC ACID MALONIC ACID; AIDS-017691; malonic acid; 1,3-Propanedioic acid; Malonic acid (8CI); propanedioic acid; Carboxyacetic acid; Methanedicarboxylic acid; C02028; METAHNEDICARBOXYLIC ACID; Dicarboxymethane; Malonate standard for IC; C04025; alpha,omega-Dicarboxylic acid; 141-82-2; AIDS017691; MLA; NSC8124; PROPANEDIOLIC ACID; Usaf ek-695; 4-02-00-01874 (Beilstein Handbook Reference); HOOC-CH2-COOH; ST5213926; 49323_FLUKA; Propanedioic acid (9CI); M1296_SIAL; 211863-95-5; nchembio.2007.22-comp12; WLN: QV1VQ; CHEBI:30794; Kyselina malonova [Czech]; Dicarboxylic acid; NSC 8124; BRN 1751370; EINECS 205-503-0; LMFA01170041; 46938U_SUPELCO; H2malo |
C3H4O4 |
104.06 g/mol |
C(C(=O)O)C(=O)O |
|
TCMBANKIN057949 |
sucrose |
Amerfand; 29253-78-9; Sucrose (TN); alpha-D-Glucopyranoside, beta-D-fructofuranosyl-; saccharose; Sugar, compressible (NF); S0389_SIGMA; D06530; C00089; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside; Sucrose, purified; 8027-47-2; 30027-72-6; 29764-06-5; 86101-30-6; NSC 406942; D06529; Sucrose [USAN:JAN]; 146187-04-4; ST5308554; Sugar, confectioner's; D(+)-Saccharose; S7903_SIGMA; GLC-(1-2)FRU; alpha-D-glucopyranosyl beta-D-fructofuranoside; FICOLL; 151756-02-4; Sugar spheres (NF); White soft sugar (JP15); Sucraloxum [INN-Latin]; Saccharum; alpha-D-Glc-(1-2)-beta-D-Fru; S9378_SIGMA; 76056-38-7; 47289_SUPELCO; D-Sucrose; Sugar spheres; 87430-66-8; 104242-10-6; (alpha-D-Glucosido)-beta-D-fructofuranoside; Table sugar; Sacharose; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; NCI-C56597; 47167-52-2; CCRIS 2120; alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer; D06528; Microse; Cane sugar; Amerfond; 64533-66-0; White soft sugar; beta-D-Fruf-(2<->1)-alpha-D-Glcp; sugar; White sugar; SUC; 84097_FLUKA; Rock candy; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; Fructofuranoside, alpha-D-glucopyranosyl, beta-D; 80165-03-3; 47257-91-0; CHEBI:17992; 47185-09-1; S5390_SIGMA; alpha-D-Glucopyranoside, beta-D-fructofuranosyl; S1888_SIGMA; 220376-22-7; D06533; 8030-20-4; S3929_SIGMA; S1174_SIGMA; 65545-99-5; Glucopyranoside, beta-D-fructofuranosyl, alpha-D; S2395_SIGMA; 78654-77-0; D06531; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; SUCROSE; S5016_SIAL; 51909-69-4; 85456-51-5; D()-Saccharose; ZINC04217475; 84100_FLUKA; D00025; Confectioner's sugar; EINECS 200-334-9; Sugar, confectioner's (NF); 57-50-1; 100405-08-1; 92004-84-7; Beet sugar; S5391_SIGMA; Sucrose, dust; alpha-D-Glc-(1->2)-beta-D-Fru; beta-D-Fructofuranosyl alpha-D-glucopyranoside; 131932-12-2; HSDB 500; Sugar, compressible; AI3-09085; alpha-D-Glucopyranosylbeta-D-fructofuranoside; Rohrzucker; 16104_RIEDEL; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; Granulated sugar; S8501_SIGMA; Sucrose, purified (JAN); 146054-35-5; Sucrose (JP15/NF); 9012-95-7; Sucrose, pure; 75398-84-4; 50857-68-6; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 25702-74-3; D(+)-Sucrose |
C12H22O11 |
342.3 g/mol |
C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O |
|
TCMBANKIN058334 |
benzene acetaldehyde |
benzeneacetaldehyde; HY1; c0210; alpha-Tolyaldehyde; 1-Oxo-2-phenylethane; 107395_ALDRICH; Acetaldehyde,phenyl- (8CI); ZINC00895323; Phenylacetic aldehyde; alpha-Tolualdehyde; NSC406309; alpha-Toluic aldehyde; 2-phenylacetaldehyde; NSC 406309; CHEBI:16424; FEMA No. 2974; 122-78-1; Phenylacetaldehyde solution; .alpha.-Tolualdehyde; W287407_ALDRICH; PHENYLACETALDEHYDE; W287415_ALDRICH; Benzylcarboxaldehyde; .alpha.-Toluic aldehyde; hyacinthin; Acetaldehyde,phenyl-; Phenylethanal; InChI=1/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H; NCIOpen2_003602; AI3-02175; 77800_FLUKA; Phenylacetaldehyde (natural); 2-Phenylethanal; Oxophenylethane; Benzeneacetaldehyde; EINECS 204-574-5; C00601; phenylacetaldehyde; Hyacinthin |
C8H8O |
120.15 g/mol |
C1=CC=C(C=C1)CC=O |
|
TCMBANKIN058367 |
indirubin |
NSC-105327; KBio2_000450; 2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one; 2-(2-oxo-3-indolinylidene)-3-indolinone; Couroupitine B; [.DELTA.2,3'-Biindoline]-2',3-dione; MLS000759416; 479-41-4; 5-24-08-00507 (Beilstein Handbook Reference); KBio3_000839; NSC105327; NSC 105327; (2E)-2-(2-ketoindolin-3-ylidene)pseudoindoxyl; KBioGR_000450; Indigopurpurin; KBioSS_000450; (2E)-2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one; indirubin ; (delta2,3'-Biindoline)-2',3-dione (8CI); 2-(2-ketoindolin-3-ylidene)pseudoindoxyl; (delta(sup 2,3')-BIINDOLINE)-2',3-DIONE; Indirubin; (2E)-2-(2-oxoindolin-3-ylidene)indolin-3-one; 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-; SMR000466311; 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro- (9CI); BRN 0088279; C.I. 73200; KBio2_005586; (2E)-2-(2-oxo-3-indolinylidene)-3-indolinone; Indigo Red; KBio2_003018; EM-A05-INDIRUBIN; 2-(2-oxoindolin-3-ylidene)indolin-3-one; KBio3_000840; Bio2_000395; Bio2_000875; (2Z)-2-(2-oxo-3-indolinylidene)-3-indolinone; (2Z)-2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-one; IDI1_002150; BSPBio_001110; NCGC00163356-01; BiomolKI2_000073; NCGC00163356-02; NCGC00163356-03; BiomolKI_000069; (2Z)-2-(2-ketoindolin-3-ylidene)pseudoindoxyl; (2Z)-2-(2-oxoindolin-3-ylidene)indolin-3-one |
C16H10N2O2 |
262.26 |
C1=CC=C2C(=C1)C(=C(N2)O)C3=NC4=CC=CC=C4C3=O |
|
TCMBANKIN058390 |
tryptanthrine |
AC1L2K2A; SMR000386951; Indolo(2,1-b)quinazoline-6,12-dione; NSC-349447; MLS001049121; SR-01000521538-1; Indolo(2,1-b)quinazoline-6,12-dione (8CI)(9CI); FT-0733127; Couroupitine a; Tryptanthrin; KS-00000C3R; C-45803; Tryptantherin; NCGC00160337-02; GNF-PF-2691; NSC349447; AK-57813; TCMDC-125859; Tryptanthrin, >=98% (HPLC); NCI60_003113; ZB000930; DS-15687; KB-254423; SR-01000521538-4; ST047334; CHEMBL306946; CJ-00188; Indolo[2,1-b]quinazoline-6,12-dione; 5941AA; NCGC00160337-01!TRYPTANTHRINE; 13220-57-0; SCHEMBL2426211; STK078931; NCGC00160337-01; AKOS000671350; Bio-0284; HMS2271H05; Indolo[2,1-b]quizoline-6,12-dione; SY017117; 11-hydrobenzo[d]quinazolino[3,2-a]azolidine-6,12-dione; ANW-68868; ZINC33299; MCULE-7521697515; CTK0H6551; TRA0036916; SR-01000521538; J-006143; AX8156048; BDBM50240612; AC1Q1HJD; TC-157613; K-4146; Tryptanthrine; D0I9AT; MFCD00012073; GTPL8224; CCG-208326; NSC 349447; AJ-08570; CHEBI:9768; DTXSID90157431; VQQVWGVXDIPORV-UHFFFAOYSA-N; C10742; Oprea1_754264; Indolo[2,12-dione; MolPort-002-516-459; AC1L2K2A; indolo[2,1-b]quinazoline-6,12-quinone; SMR000386951; Indolo(2,1-b)quinazoline-6,12-dione; NSC-349447; MLS001049121; SR-01000521538-1; Indolo(2,1-b)quinazoline-6,12-dione (8CI)(9CI); FT-0733127; Couroupitine a; Tryptanthrin; KS-00000C3R; C-45803; Tryptantherin; NCGC00160337-02; GNF-PF-2691; NSC349447; AK-57813; TCMDC-125859; Tryptanthrin, >=98% (HPLC); NCI60_003113; ZB000930; DS-15687; KB-254423; SR-01000521538-4; ST047334; CHEMBL306946; CJ-00188; tryptanthrin ; Indolo[2,1-b]quinazoline-6,12-dione; 5941AA; NCGC00160337-01!TRYPTANTHRINE; 13220-57-0; SCHEMBL2426211; STK078931; NCGC00160337-01; AKOS000671350; Bio-0284; indolo[2,1- b]quinazoline alkaloid; HMS2271H05; indolo-[2,1-b]-quinazoline-6,12-dione; Indolo[2,1-b]quizoline-6,12-dione; SY017117; 11-hydrobenzo[d]quinazolino[3,2-a]azolidine-6,12-dione; ANW-68868; ZINC33299; MCULE-7521697515; CTK0H6551; TRA0036916; AIDS017287; SR-01000521538; J-006143; ZINC00033299; AX8156048; BDBM50240612; 6,12-dihydro-6, 12-dioxoindolo-(2,1-b)-quinazoline; AC1Q1HJD; TC-157613; K-4146; Tryptanthrine; D0I9AT; MFCD00012073; GTPL8224; CCG-208326; NSC 349447; AJ-08570; AIDS-017287; CHEBI:9768; DTXSID90157431; VQQVWGVXDIPORV-UHFFFAOYSA-N; C10742; Oprea1_754264; Indolo[2,12-dione; MolPort-002-516-459; tryptanthrin |
C15H8N2O2 |
248.24 g/mol |
C1=CC=C2C(=C1)C(=O)N3C4=CC=CC=C4C(=O)C3=N2 |
|
TCMBANKIN058781 |
Toddaculin |
5,7-dimethoxy-6-(3-methylbut-2-enyl)coumarin; 4335-12-0; Toddaculine; 5,7-dimethoxy-6-(3-methylbut-2-enyl)-2-chromenone; 5,7-dimethoxy-6-(3-methylbut-2-enyl)chromen-2-one; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-6-(3-methyl-2-butenyl)-; toddaculine |
C16H18O4 |
274.31 g/mol |
CC(=CCC1=C(C=C2C(=C1OC)C=CC(=O)O2)OC)C |
|
TCMBANKIN058851 |
linalool |
Spectrum5_000393; KBioGR_002294; KBio2_003260; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; W263516_ALDRICH; ZINC01529820;beta-linalool;NSC-3789; AK-50127; (+/-)-3,7-Dimethyl-1,6-octadien-3-ol; ACMC-209pf1; D0X5DC; Linalool Solution, 1000 mg/L, 1 ml (RM, ISO GUIDE 34); Linalool, primary pharmaceutical reference standard; CDOSHBSSFJOMGT-UHFFFAOYSA-N; AC1L1MRY; Howood Oil; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3S)-; KSC377K8J; AC1Q1NVD; KB-179981; (+/-) LINALOOL; NCGC00259207-01; 3,6-dien-3-ol; AI3-00942; HSDB 645; (S)-Linalol; 2,7-Octadien-6-ol, 2,6-dimethyl-; 2,6-Dimethylocta-2,7-dien-6-ol; Linalool ex orange oil; (?)-3,7-Dimethyl-1,6-octadien-3-ol; DB-062552; I14-13929; FT-0614785; FCH1115719; Tox21_201658; 11024-20-7; BB_NC-00123; MolPort-001-783-101; LS-97796; 2,6-Dimethyl-2,7-octadien-6-ol; Linalool (natural); L0048; Linalool; BRN 1721488; 2,7-octadiene-6-ol; DSSTox_RID_77812; 3,7-Dimethyl-1,6-octadien-3-ol; BC207603; STL373777; AC1Q2BP3; FEMA No. 2635; ANW-37211; MCULE-2407576698; 3,6-octadien-3-ol; Natural Linalool; Linalool b; SCHEMBL20316; BBL027734; EINECS 204-811-2; LINALOOL (+); CU-01000013132-2; LINOLOOL (D); ST069326; dl-3,7-Dimethyl-3-hydroxy-1,6-octadiene; NSC 3789; CHEBI:17580; Linalool ex ho oil; Linalool, 97%; (.+/-.)-Linalool; allo-Ocimenol; GTPL2469; CCRIS 6557; ( -)-Linalool; BG00600803; NCGC00257060-01; C03985; EINECS 201-134-4; HMS2268E18; Tox21_303037; Phantol; (+-)-Linalool; SBB012353; SMR000112394; DTXSID7025502; (R)-3,7-Dimethyl-1,6-octadien-3-ol; DL -3,7-Dimethyl-3-hydroxy-1,6-octadiene; BB_NC-0123; NCGC00091688-04; (+/-)-3,7-Dimethyl-3-hydroxy-1,6-octadiene; CHEMBL25306; MLS002152908; WLN: 1Y1&U3XQ1&1U1 -,-; LINALYL ALCOHOL; Q-201306; 0-01-00-00462 (Beilstein Handbook Reference); SC-74998; CAS-78-70-6; (+/-)-linalool; LINALOOL EX BOIS DE ROSE; RTR-030706; NCGC00091688-02; Linalool, analytical standard; MFCD00008906; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; Linalool, >=97%, FCC, FG; AC-551; Linolool; NSC3789; Linalool, certified reference material, TraceCERT(R); FEMA Number 2635; AKOS015901617; 3,7-Dimethyl-1, 6-octadien-3-ol; p-Linalool; Linalool ex bois de rose oil; FEMA 2635; DSSTox_CID_5502; .beta.-Linalool; EC 201-134-4; TR-030706; CTK2H7584; LS-1752; KS-00000WLW; 3,7-Dimethylocta-1,6-dien-3-ol; DSSTox_GSID_25502; WLN: 1U1XQ1&3UY1&1; 1,6-Octadien-3-ol, 3,7-dimethyl-; ( )-linalool; CCRIS 3726; Linanool; 78-70-6; NCGC00091688-03; Caswell No. 526A; AN-22986; 2,6-Dimethyl-2,7-octadiene-6-ol; (RS)-Linalool; RP21877; (1)-3,7-Dimethyl-1,6-octadien-3-ol; AN-15757; AC1Q1NVE; LINALOOL, (+-)-; NCGC00091688-01; Linalol; beta-Linalool; EINECS 245-083-6; 22564-99-4; Linalool, .beta.; 2,7-dien-6-ol; EPA Pesticide Chemical Code 128838; 1, 3,7-dimethyl-, (-)-; 3,7-dimethyl-octa-1,6-dien-3-ol;L-linalool;CJ-23937; Spectrum5_000393; LMPR0102010013; AKOS028109218; linalool ; Linalool; 1,6-Octadien-3-ol,3,7-dimethyl-, (3R)-; (R)-3,7-Dimethyl-1,6-octadien-3-ol; AC1L9E4Q; KBioGR_002294; (R)-3,7-dimethylocta-1,6-dien-3-ol; KBio2_003260; Epoxydihydrolinalool; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; ZINC1529820; Spectrum4_001777; C11388; linalool oxide; 126-91-0; 3U21E3V8I2; KBio3_002285; CCG-38497; CTK8F1408; KBio2_005828; KBioSS_000692; (-)-Linalool; EINECS 204-811-2; (-)-3,7-dimethyl-1,6-octadien-3-ol; LINALOOL (+); (3R)-Linalool; L-LINALOOL, REF. IND.-14<F128><144><F255>; CHEMBL235672; CHEBI:28; SpecPlus_000909; SCHEMBL891312; (-)-Linalool, analytical standard; UNII-3U21E3V8I2; KBio1_001949; J-005448; MolPort-003-666-060; NCGC00095658-01; FT-0772303; BSPBio_002785; SDCCGMLS-0066889.P001; UNII-D81QY6I88E component CDOSHBSSFJOMGT-JTQLQIEISA-N; L-Linalool; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; L-Linalool, natural, >=95%, FG; SPBio_002007; Spectrum3_001173; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3R)-; NCGC00095658-02; SPECTRUM1501212; SMP2_000331; (-)-Linalool, >=95.0% (sum of enantiomers, GC); Linalool, (-)-; 3R,7-dimethylocta-1,6-dien-3-ol; DivK1c_007005; (R)-linalool; (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol; DTXSID40872607; laevo-linalool; MFCD00135469; Spectrum2_001944; I14-45868; (3R)-3,7-dimethyl-1,6-octadien-3-ol; Spectrum_000212; (R)-(-)-Linalool |
C10H18O |
154.25 g/mol |
CC(=CCCC(C)(C=C)O)C |
|
TCMBANKIN058861 |
ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf |
ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf |
C48H82O18 |
947.15 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
|
TCMBANKIN058862 |
gypenoside lxxviii |
|
C41H70O13 |
|
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CC(C(C4(C)C)O)O)C)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)C |
|
TCMBANKIN058865 |
ginsenoside-F2 |
ginsenoside- F2; ginsenoside f2 |
C42H72O13 |
785.01 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C |
|
TCMBANKIN058867 |
ginsenoside rb1 |
Q-100470; A-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl ; GRb 1; MFCD00133367; ginsenosiderb1; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root, triterpenoid saponin; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; N1620; NSC 310103; CHEBI:67989; Ginsenoside Rb1, primary pharmaceutical reference standard; C20713; Panax saponin E; 7413S0WMH6; Pseudoginsenoside D; 87700-07-0; A-Glucopyranosyl-(3; C54H92O23; A)-20-[(6-O-; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; Ginsenoside Rb1, European Pharmacopoeia (EP) Reference Standard; (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-ginsenoside Rb1; 2-O-; Ginsenoside Rb1 (saponin of panax ginseng); 52286-61-0; 12770-17-1; 393829-67-9; CS-3829; BIDD:ER0108; A,12; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside; GZYPWOGIYAIIPV-JBDTYSNRSA-N; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root; GS-Rb1; 41753-43-9; ginsenoside-rb1; ginsenoside r b1; 212055-66-8; UNII-7413S0WMH6; AB0016710; AKOS025311537; A-D-glucopyranoside; Ginsenoside rb1; MolPort-016-638-397; gensenoside Rb1; Gypenoside III; ginsenoside Rb1; CHEMBL501515; HY-N0039; Gynosaponin C; BDBM50317541; (3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Ambap41753-43-9; GSRb1; Ginsenoside-Rb1; 753G439; Sanchinoside E1; A-D-glucopyranosyl-; Panaxsaponin E; O899; ginsenoside-Rb1;gypenosideIII |
C54H92O23 |
1109.3 g/mol |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C |
|
TCMBANKIN058869 |
ginsenoside Rb3 |
ginsenoside rb3; ginsenoside r b3; gensenoside- Rb3; ginsenoside- Rb3; gensenoside Rb3; ginsenosiderb3; ginsenoside-rb3 |
C53H90O22 |
1079.3 g/mol |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
|
TCMBANKIN058875 |
Malonylginsenoside Rd |
malonylginsenosiderd; malonyl ginsenoside Rd; malonylginsenoside rd |
C51H84O21 |
1033.2 g/mol |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)COC(=O)CC(=O)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
|
TCMBANKIN058879 |
Gypenoside XLII |
gypenoside xlii |
C54H92O24 |
1125.29 |
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C |
|
TCMBANKIN059249 |
CLR |
5-Cholesten-3b-ol; Hydrocerin; 5:6-Cholesten-3beta-ol; 209124-38-9; Lidinite; 5:6-Cholesten-3.beta.-ol; Tegolan (VAN); C1231_SIGMA; 3-beta-Hydroxycholest-5-ene; Delta5-Cholesten-3beta-ol; C3292_SIGMA; (3H)-Cholesterol; 20808_RIEDEL; S5442_SIGMA; Cholest-5-en-3-ol, (3-.beta.)-; Super hartolan; Cholesterol (JP15/NF); AIDS338945; 5:6-Cholesten-3-ol; nchembio782-comp1; 3beta-Hydroxy-5-cholestene; delta(sup 5)-Cholesten-3-beta-ol; Dusoline; CHOLESTEROL; D00040; C00187; Provitamin D; Wool alcohols B. P.; Cholest-5-en-3-ol, (3beta)-; Synthetic cholesterol; Dythol; CMC_13392; HSDB 7106; 3beta-Hydroxycholest-5-ene; Cordulan; 5,6-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 57-88-5; Kathro; Dusoran; (3beta)-cholest-5-en-3-ol; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; 3.beta.-Hydroxycholest-5-ene; 26740_FLUKA; Cholesterol base H; Cholest-5-en-3-ol (3beta)-, labeled with tritium; NCGC00159351-02; 80356-14-5; Cholest-5-en-3-ol, (3.beta.)-; Cholestrin; 5-Cholesten-3beta-ol; ZINC03875383; 218965-24-3; 26732_FLUKA; Cholesterin; C8667_SIGMA; 22243-67-0; Lidinit; Phospholipon & Cholesterol; CHEBI:16113; SyntheChol NS0 Supplement; NSC 8798; nchembio.77-comp1; AI3-03112; Lanol; Cholestrol; AIDS080405; Cholest-5-en-3-ol (3beta)-; 5-Cholesten-3.beta.-ol; SyntheChol; NSC8798; Cholesterol solution; Cholesterol [USAN:JAN]; Nimco cholesterol base H; C8503_SIGMA; BB_NC-0135; SMP1_000069; C3137_SIGMA; Cholesterine; 47127U_SUPELCO; Cholest-5-en-3-beta-ol; Nimco cholesterol base No. 712; AIDS-338945; Cholesteryl alcohol; C3045_SIGMA; 14606_FLUKA; Soya phospholipon & Cholesterol (2:1 molar ratio); AIDS-080405; LMST01010001; CCRIS 2834; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholest-5-en-3beta-ol; Cholesterol (TN); EINECS 200-353-2; Tegolan;cholesterol;8(14)-dehydrocholesterol; 177962-82-2; SCHEMBL5347436; cholesta-5,8(14)-dien-3beta-ol; DJNCIOAUQVURTQ-RQZUOROGSA-N |
C27H46O |
386.65 |
CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
|
TCMBANKIN059527 |
(+)-Camphene |
|
C10H16 |
136.23 g/mol |
CC1(C2CCC(C2)C1=C)C |
|
TCMBANKIN059546 |
Gypenoside LXIX |
|
C53H90O22 |
1079.27 |
CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C(C)(CC=CC(C)(C)O)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C)O)C)C |
|
TCMBANKIN059651 |
NSC 308879 |
|
C30H52O3 |
460.73 |
CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)O)C)C)O)C)C |
|
TCMBANKIN059724 |
Phenol, 2-methyl-5-(1-methylethyl) |
|
C10H14O |
150.22 g/mol |
CC1=C(C=C(C=C1)C(C)C)O |
|
TCMBANKIN059838 |
Acetylthymol |
|
C12H16O2 |
192.25 g/mol |
CC1=CC(=C(C=C1)C(C)C)OC(=O)C |
|
TCMBANKIN059908 |
xylene |
|
C8H10 |
106.17 |
CC1=CC=C(C=C1)C.CC1=CC(=CC=C1)C.CC1=CC=CC=C1C |
|
TCMBANKIN059947 |
vitamin b1 |
|
C63H88CoN14O14P |
1356.4 g/mol |
CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2] |
|
TCMBANKIN060183 |
ginsenoside- Re |
|
C48H82O18 |
947.15 |
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O |
|
TCMBANKIN060261 |
Gypenoside XLVII |
|
C54H92O24 |
1125.29 |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C)(CCC=C(C)C)C3CCC4(C3C(CC5C4(CCC6C5CCC(C6(C)C)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)O)C)O)O)O)O)O)O |
|
TCMBANKIN060264 |
rutin |
|
C27H30O16 |
610.5 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O |
|
TCMBANKIN060695 |
24alpha-ethyl-5alpha-cholestan-3beta-ol |
|
C29H52O |
416.72 |
CCC(CCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C)C(C)C |
|
TCMBANKIN060769 |
phosphatidylserine |
|
C13H24NO10P |
385.3 g/mol |
CCCC(=O)OC(COC(=O)CC)COP(=O)(O)OCC(C(=O)O)N |
|
TCMBANKIN060879 |
Linolic acid |
|
C18H32O2 |
280.4 g/mol |
CCCCCC=CCC=CCCCCCCCC(=O)O |
|
TCMBANKIN060957 |
ELD |
|
C18H35NO |
281.48g/mol |
CCCCCCCCC=CCCCCCCCC(=O)N |
|
TCMBANKIN060958 |
oleic acid;cis-oleic acid;oleinic acid |
|
C18H34O2 |
282.46 |
CCCCCCCCC=CCCCCCCCC(=O)O |
|
TCMBANKIN061047 |
cerebroside b |
|
C41H77NO9 |
728.1 g/mol |
CCCCCCCCCCCCCCC(C(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCC=C(C)CCCCCCCCC)O)O |
|
TCMBANKIN061071 |
Ethylpalmitate |
|
C18H36O2 |
284.5 g/mol |
CCCCCCCCCCCCCCCC(=O)OCC |
|
TCMBANKIN061090 |
n-octadecane;Oktadekan;octadecane |
|
C18H38 |
254.49g/mol |
CCCCCCCCCCCCCCCCCC |
|
TCMBANKIN061091 |
stearic acid |
|
CH3(CH2)16COOH |
284.5 g/mol |
CCCCCCCCCCCCCCCCCC(=O)O |
|
TCMBANKIN061122 |
tricosane |
|
C23H48 |
324.63 g/mol |
CCCCCCCCCCCCCCCCCCCCCCC |
|
TCMBANKIN061224 |
methyl propyl disulfide |
|
C4H10S2 |
122.3 g/mol |
CCCSSC |
|
TCMBANKIN061451 |
5,2'-Dihydroxy-6,7,8-trimethoxyflavone |
86926-52-5; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(2-hydroxyphenyl)-6,7,8-trimethoxy-; 5-hydroxy-2-(2-hydroxyphenyl)-6,7,8-trimethoxy-chromen-4-one; 5-hydroxy-2-(2-hydroxyphenyl)-6,7,8-trimethoxychromen-4-one; 5,2'-dihydroxy-6,7,8-trimethoxyflavone; 5-hydroxy-2-(2-hydroxyphenyl)-6,7,8-trimethoxy-chromone; 5-hydroxy-2-(2-hydroxyphenyl)-6,7,8-trimethoxy-4-chromenone; tenaxin i |
C18H16O7 |
344.32 |
COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3O)OC)OC |
|
TCMBANKIN061614 |
3'-methyleriodictyol |
EINECS 207-173-3; homoeriodictyol; NCGC00163565-01; C09756; AIDS058011; (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone; 446-71-9; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-, (2S)-; AIDS-058011; homoeriodictyol ; (2S)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-chromanone; (2S)-5,7-dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chroman-4-one; Eriodictyol 3'-methyl ether; (2S)-5,7-;dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chroman-4-one; (-)-Homoeriodictyol;3'-Methyl eriodictyol-7-O-beta-D-glucoside_qt; 3'-Methyl eriodictyol |
C16H14O6 |
302.28 |
COC1=C(C=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O |
|
TCMBANKIN061868 |
o-methoxy phenol |
2-methoxyphenol;guaiacol;Guasol;Catechol mono methyl ether; DSSTox_RID_77552; SMR000059155; ANW-13634; Anastil; WLN: QR BO1; 2-Methoxyphenol; Catechol monomethyl ether; Pyrocatechol monomethyl ether; CHEMBL13766; SCHEMBL21626; AI3-05615; DB-024854; 6JKA7MAH9C; Guajacol; Guaiacol (2-Methoxyphenol); 2-Methoxyphenol, 98% 250g; 2-methoxyphenol;; Methyl Catechol; CAS-90-05-1; Guaiacol, Pharmaceutical Secondary Standard; Certified Reference Material; HMS3372N11; Guaiacol [JAN:NF]; 2-Methoxy-Phenol; 3-hydroxy-2-methoxyphenyl; 2-methoxy phenol; SBB058681; a hydroxlyated aryl lignin fragment; NCGC00090827-06; Guaiacol, Vetec(TM) reagent grade, 98%; UNII-6JKA7MAH9C; D00117; 26638-03-9; 7519-EP2295426A1; 7519-EP2316470A2; Guaicol; Guaiacol, oxidation indicator; guaiacol; Creosote (wood); guiacol; SR-01000838056-3; 2-Hydroxyanisole; Creosote, beechwood; DTXSID0023113; 7519-EP2308857A1; CCRIS 6004; o-Hydroxyanisole; AJ-63992; ZINC13512224; SR-01000838056-2; EINECS 232-419-1; RCRA waste number U051; 7519-EP2305636A1; C01502; Beechwood creosote; 2-(methyloxy)phenol; 196981-EP2371803A1; SC-18105; A843426; HMS2233P04; LHGVFZTZFXWLCP-UHFFFAOYSA-N; Guaiacol, natural, >=99%, FG; HMS2089D18; AB00876226_07; Tox21_202990; MFCD00002185; Guaiastil; guaiacol (liquid) extra pure; bmse000436; NCGC00090827-03; CREOSOTE, WOOD; orthomethoxyphenol; AB00876226-06; 7519-EP2305683A1; 2-Methoxyphenol, Catechol monomethyl ether, Pyrocatechol monomethyl ether; NSC3815; Guaiacol [JAN]; methoxy phenol; AK114448; 6-methoxyphenol; Guajakol [Czech]; NCGC00090827-02; ST2410094; FEMA No. 2532; EC 201-964-7; CS-D1347; Methylcatachol; Guaiacol, SAJ first grade, >=98.0%; Creosote [JAN]; 7519-EP2308861A1; JZ3; STL281868; InChI=1/C7H8O2/c1-9-7-5-3-2-4-6(7)8/h2-5,8H,1H; o-Guiacol; HSDB 1979; NCGC00090827-01; SR-01000838056; M0121; 7519-EP2316832A1; DSSTox_CID_3113; o-methoxy-Phenol; Guaiacol (natural); Tox21_400004; Guaiacol, European Pharmacopoeia (EP) Reference Standard; ortho-Guaiacol; Guajakol; Phenol, 2-methoxy-; PS-3252; Guaicolina; ACMC-209784; EBD2205193; NSC-760376; Pyrocatechol monomethyl ether; 7519-EP2314584A1; D02JUW; NSC760376; C15572; AN-17339; 7519-EP2311839A1; Phenol, o-methoxy-; Wood creosote; 2-Methoxyphenol; Creosote; Tox21_111031; 7519-EP2314589A1; AB1001888; ortho-methoxyphenol; CCG-214035; bmse010027; Creosote (wood tar); AC1Q46B5; I01-6054; 1-Hydroxy-2-methoxybenzene; o--methoxyphenol; TR-028311; LS-1906; NCGC00090827-07; 7519-EP2316837A1; 7519-EP2316833A1; EINECS 201-964-7; BDBM50240369; 196981-EP2269977A2; KS-00000KSX; 1990/5/1; Guajol; AC1L19AA; ST50214385; 7519-EP2295427A1; o-Guaiacol; CAS-8021-39-4; Guasol; HSDB 4241; MLS001055375; NCGC00090827-04; 8021-39-4; RTR-028311; ghl.PD_Mitscher_leg0.900; DSSTox_RID_76880; Pyroguaiac acid; MolPort-000-871-969; NCGC00090827-05; UNII-3JYG22FD73; Beechwood creosote (Fagus spp.); Creodon (TN); Pharmakon1600-01506165; Hydroxyanisole; Nat.Guaiacol; F2173-0425; 2-methoxyl-4-vinylphenol; O-Methyl catechol; o-Methoxyphenol; Creodon; CTK1A4914; KB-30331; Guaiacol (JAN); NCGC00258688-01; Pyrocatechol methyl ester; DB11359; 7519-EP2311821A1; Methylcatechol; AKOS000118831; Guaiacol, puriss., 99%; 3JYG22FD73; NSC 3815; NCGC00260535-01; Catechol monomethyl ether; STR03604; Guaiacol, United States Pharmacopeia (USP) Reference Standard; HMS3715E11; 1- hydroxy-2-methoxybenzene; KSC204S1J; 7519-EP2292227A2; DSSTox_GSID_24853; 196981-EP2377843A1; FT-0626815; NSC-3815; MCULE-5627336368; Q-100002; CCRIS 2943; 2-methoxyphenol (guaiacol); CHEBI:28591; DSSTox_GSID_23113; Phenol, methoxy-; Tox21_201136;HSDB 4241; 90-05-1; Anastil; 8021-39-4; Guaicolina; ZINC00001521; WLN: QR BO1; ghl.PD_Mitscher_leg0.900; Pyrocatechol monomethyl ether; 50880_FLUKA; AI3-05615; Pyroguaiac acid; Guaiastil; Methoxyphenol; AIDS-107096; NCGC00090827-03; CREOSOTE, WOOD; Guajacol; Creodon (TN); NSC3815; Guaiacol [JAN]; C15572; Creodon; o-Methoxyphenol; 2-Methoxyphenol; Guajakol [Czech]; O-Methyl catechol; Phenol, o-methoxy-; NCGC00090827-02; Guaiacol (JAN); W253200_ALDRICH; D00117; FEMA No. 2532; Pyrocatechol methyl ester; Methylcatechol; 26638-03-9; Guaicol; CPD-400; NSC 3815; InChI=1/C7H8O2/c1-9-7-5-3-2-4-6(7)8/h2-5,8H,1H; guaiacol; NCGC00090827-01; Catechol monomethyl ether; G5502_SIGMA; ST5214385; 1-Hydroxy-2-methoxybenzene; 2-Hydroxyanisole; AIDS107096; o-Hydroxyanisole; Guaiacol (natural); EINECS 201-964-7; Phenol, 2-methoxy-; Guajol; CCRIS 2943; C01502; o-Guaiacol; CHEBI:28591; Phenol, methoxy- |
C7H8O2 |
124.14 g/mol |
COC1=CC=CC=C1O |
|
TCMBANKIN061927 |
methoxyacetic acid cyclopentyl ester |
2-methoxyacetic acid cyclopentyl ester; Methoxyacetic acid, cyclopentyl ester; cyclopentyl 2-methoxyethanoate |
C8H14O3 |
158.19 g/mol |
COCC(=O)OC1CCCC1 |
滇ICP备16009434号-1 |
Dai SX Lab